NSE filing, NSE: GLAND. Summary written from the filing by ALFA Finder's alert engine.
Gland Pharma Ltd: key numbers
- Share price
- ₹3,095.90
- Market cap
- ₹51,086 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 45.3×Sector 48.7×
- Promoter holding
- 45.75%-6.02% QoQ
- FII holding
- 10.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gland Pharma Ltd
All →Gland Pharma Business Update
Gland Pharma reports that USFDA concluded an unannounced cGMP inspection at its Dundigal formulation facility with four procedural Form 483 observations. No monetary impact is stated, and corrective actions will be submitted within the stipulated period.
Gland Pharma Board Meeting Date
Gland Pharma Ltd scheduled a board meeting for November 06, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2026.
Gland Pharma Other Announcement
Gland Pharma Limited has filed the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Gland Pharma Annual General Meeting
Gland Pharma issued a postal ballot notice to seek shareholder approval for appointing Mr. Xingli Wang as Non-Executive Director. E-voting runs October 7 to November 5, 2026.
Gland Pharma Management Change
Gland Pharma Limited announced the resignation of director Wenjie Zhang and the appointment of Xingli Wang as a Non-Executive Non-Independent Director effective October 1, 2026.
Gland Pharma Acquisition Worth ₹199.5 Cr
Gland Pharma Limited's board approved a USD 21 million investment in its subsidiary, Gland USA, to acquire a 60% stake in Novelstar Pharma Inc. This acquisition facilitates business expansion in the USA.
- Value
- ₹199.5 Cr
- Execution
- By October 31, 2026
Other management change announcements
All →Cubical Financial Services Management Change
Cubical Financial Services changed its Chairperson on 30 October 2026, with Ritu Bansal succeeding Ashwani Kumar Gupta. The board approved the change at a meeting held the same day.
Amarjothi Spinning Mills Management Change
Amarjothi Spinning Mills disclosed the resignation of V.E. Selvaraj, General Manager (Operations & Admin) and SMP, effective close of business 31 October 2026, citing personal reasons. The filing is a senior management change.
P S Raj Steels Management Change
P S Raj Steels noted the resignation of Company Secretary Harshita Arora, effective 9 October 2026. The board also reconstituted its Nomination and Remuneration Committee.
Shining Tools Management Change
Shining Tools appointed Keyur Dhirubhai Sakhiya as Chief Financial Officer and KMP effective 30 Oct 2026, per a board meeting held 29 Oct 2026. The filing gives his profile, with no monetary value.
Advait Energy Transitions Management Change
Advait Energy Transitions appointed Vimal Kishore Yadav as Chief Operating Officer, effective 30 October 2026. He brings about two decades of energy infrastructure experience.
Rexpro Enterprises Management Change
Rexpro's Company Secretary and Compliance Officer, Abhishek Surendra Yadav, resigned effective October 30, 2026. The resignation cites personal reasons and no other material reasons.